Evidence map›Paper›PMID 32152084›Full record

ArticleAntimicrobial agents and chemotherapy2020

Characterization of

Nao Matsuo, Rina Nonogaki, Michiko Hayashi, Jun-Ichi Wachino, Masahiro Suzuki, Yoshichika Arakawa, Kumiko Kawamura

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Phenotypic and Genetic Characteristics ofInternational journal of molecular sciences · 2026
    Article
  2. Plasmid-mediated acquisition and chromosomal integration ofAntimicrobial agents and chemotherapy · 2024
    Article
  3. Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades ofAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Detection of Clones B2-ST131-C2 and A-ST617 inAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Resistome and Virulome of Multi-Drug ResistantDiagnostics (Basel, Switzerland) · 2022
    Article
  8. A Novel Structure HarboringAntibiotics (Basel, Switzerland) · 2021
    Article
  9. ESBL andFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nao Matsuo *Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Rina Nonogaki *Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Michiko HayashiDepartment of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jun-Ichi WachinoDepartment of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masahiro SuzukiDepartment of Microbiology, Fujita Health University, Toyoake, Japan.
Yoshichika ArakawaDepartment of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kumiko KawamuraDepartment of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan kumiko@met.nagoya-u.ac.jp.
Nagoya University · JPFujita Health University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We characterized 29

Indexed as

AdultAged, 80 and overAnti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHigh-Throughput Nucleotide SequencingHumansJapanLong-Term CareMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsSequence Analysis, DNAAnti-Bacterial Agentsbeta-LactamasesCTX-M-27, E coliEscherichia coli ProteinsblaCTX-M-27elderly peopleF1:A2:B20 plasmidnext-generation sequencing analysis

Identifiers

PMID32152084
PMCPMC7179624
OpenAlexW3012367844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.